Quick Take
Shockwave Medical (SWAV) intends to raise gross proceeds of $70 million from a U.S. IPO, according to an S-1 registration statement.
The firm has developed a sonic wave catheter system for the treatment of calcified plaque.
SWAV seeks public capital to fund commercialization and further development of its medical devices.
I’ll provide an update when we learn more details from management.
Company & Technology
Santa Clara, California-based Shockwave Medical was founded in 2009 to improve patient outcomes via their intravascular lithotripsy [IVL] system that uses sonic pressure waves for the